Keith Robison
Active 1994–2022
- Affiliations
- Infinity Pharmaceuticals (United States)This corpus build does not record the country of an author's affiliations, so none is shown here. It does not mean these institutions have no country.
- ORCID
- 0000-0001-5566-382X
- 19
- Papers
- 6,605
- Citations
- 18
- h-index
- 18
- i10-index
Self-citations are included in these numbers.
Citations per year
Citations
- 1 year (1 citations) is not shown (dated before this author's first paper)
Citation sources
Countries
This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.
Institutions
Fields
- Medicine52%
- Biochemistry, Genetics and Molecular Biology35.8%
- Immunology and Microbiology5.4%
- Computer Science1.7%
- Agricultural and Biological Sciences1.2%
- Chemistry0.9%
- Other3%
Topics
- Renin-Angiotensin System Studies16%
- COVID-19 Clinical Research Studies15.7%
- SARS-CoV-2 and COVID-19 Research14%
- Hormonal Regulation and Hypertension8.5%
- Long-Term Effects of COVID-196%
- Redox biology and oxidative stress5.8%
- Other33.9%
Frequent coauthors
- Alex Plocik3
- Birgitte B. Simen3
- George M. Church3
- Alessandro Zulli2
- Chaney C. Kalinich2
- Chantal B. F. Vogels2
- Chris Tunkey2
- Claire Duvallet2
- Isabel M. Ott2
- Jasmijn A. Baaijens2
- John Bertin2
- Jordan Peccia2
- Joseph R. Fauver2
- Kyle A. McElroy2
- M Pierson2
- Malaika Mckenzie-Bennett2
- Mallery I. Breban2
- Mary E. Petrone2
- Maxim Imakaev2
- Michael Baym2
- Michelle Spencer2
- Nathan D. Grubaugh2
- Newsha Ghaeli2
- Peter S. DiStefano2
All papers
Loading papers…
